In patients with HIV infection, continuing or discontinuing abacavir in the dolutegravir/lamivudine combination is linked to similar weight gains and comparable metabolic parameters.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/stopping-abacavir-not-linked-weight-gain-hiv-care-2025a1000opk?src=rss
Author :
Publish date : 2025-09-18 08:21:00
Copyright for syndicated content belongs to the linked Source.